Quadrant Capital Group’s Allogene Therapeutics ALLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.8K	Hold	4,853	–	–	﹤0.01%	2154
2025 Q4	$6.65K	Buy	+4,853	New	+$6.4K	﹤0.01%	2306
2025 Q2	–	Sell	-4,880	Closed	-$7.13K	–	1374
2025 Q1	$7.13K	Buy	4,880 +4,509	+1,215%	+$8.5K	﹤0.01%	2285
2024 Q4	$791	Sell	371 -389	-51%	-$959	﹤0.01%	2611
2024 Q3	$2.13K	Buy	+760	New	+$2.03K	﹤0.01%	2489
2024 Q2	–	Sell	-1,414	Closed	-$6.32K	–	2701
2024 Q1	$6.32K	Hold	1,414	–	–	﹤0.01%	2253
2023 Q4	$4.54K	Sell	1,414 -2,176	-61%	-$6.17K	﹤0.01%	2297
2023 Q3	$11.4K	Buy	3,590 +3,104	+639%	+$13.6K	﹤0.01%	1941
2023 Q2	$2.42K	Sell	486 -68	-12%	-$368	﹤0.01%	2375
2023 Q1	$2.74K	Buy	554 +518	+1,439%	+$3.32K	﹤0.01%	2368
2022 Q4	$226	Sell	36 -790	-96%	-$7.31K	﹤0.01%	2690
2022 Q3	$9K	Hold	826	–	–	﹤0.01%	1913
2022 Q2	$9K	Sell	826 -587	-42%	-$5.21K	﹤0.01%	1695
2022 Q1	$13K	Buy	1,413 +1,055	+295%	+$11K	﹤0.01%	1521
2021 Q4	$5K	Buy	358 +272	+316%	+$4.8K	﹤0.01%	1850
2021 Q3	$2K	Buy	86 +78	+975%	+$1.85K	﹤0.01%	2099
2021 Q2	$0	Buy	+8	New	+$228	﹤0.01%	2396